These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 21242480)

  • 1. Overview of the 2010 Food and Drug Administration Cardiovascular and Renal Drugs Advisory Committee meeting regarding ticagrelor.
    Gaglia MA; Waksman R
    Circulation; 2011 Feb; 123(4):451-6. PubMed ID: 21242480
    [No Abstract]   [Full Text] [Related]  

  • 2. Ticagrelor: a novel oral antiplatelet agent.
    Huang NS; Master HH; Fusco JA; Park ZH
    Consult Pharm; 2010 Nov; 25(11):745-55. PubMed ID: 21138823
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ticagrelor: from discovery to Phase III clinical trial.
    Siller-Matula JM; Jilma B
    Future Cardiol; 2010 Nov; 6(6):753-64. PubMed ID: 21142630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New antiplatelet agents in the treatment of acute coronary syndromes.
    Sabouret P; Taiel-Sartral M
    Arch Cardiovasc Dis; 2014 Mar; 107(3):178-87. PubMed ID: 24630752
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ticagrelor: a new option for ACS.
    Belavic JM
    Nurse Pract; 2012 Mar; 37(3):9-11. PubMed ID: 22334097
    [No Abstract]   [Full Text] [Related]  

  • 6. [Using ADP receptor antagonists in coronary heart disease and acute coronary syndrome].
    Schreiber P; Fauchère I; Wyss C
    Praxis (Bern 1994); 2014 Sep; 103(18):1049-58. PubMed ID: 25183612
    [No Abstract]   [Full Text] [Related]  

  • 7. Ticagrelor--a new platelet aggregation inhibitor in patients with acute coronary syndromes. An improvement of other inhibitors?
    Kowalczyk M; Banach M; Mikhailidis DP; Hannam S; Rysz J
    Med Sci Monit; 2009 Dec; 15(12):MS24-30. PubMed ID: 19946242
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluating the risk-benefit profile of the direct-acting P2Y(12) inhibitor ticagrelor in acute coronary syndromes.
    Husted S
    Postgrad Med; 2011 Nov; 123(6):79-90. PubMed ID: 22104457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Switching antiplatelet regimens: alternatives to clopidogrel in patients with acute coronary syndrome undergoing PCI: a review of the literature and practical considerations for the interventional cardiologist.
    Azmoon S; Angiolillo DJ
    Catheter Cardiovasc Interv; 2013 Feb; 81(2):232-42. PubMed ID: 22581463
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ADP-receptor inhibitors in the perioperative period: the good, the bad, and the ugly.
    Oprea AD; Popescu WM
    J Cardiothorac Vasc Anesth; 2013 Aug; 27(4):779-95. PubMed ID: 23648080
    [No Abstract]   [Full Text] [Related]  

  • 11. Ticagrelor approved for acute coronary syndrome.
    Traynor K
    Am J Health Syst Pharm; 2011 Sep; 68(17):1568. PubMed ID: 21856798
    [No Abstract]   [Full Text] [Related]  

  • 12. Ticagrelor (Brilinta)--better than clopidogrel (Plavix)?
    Med Lett Drugs Ther; 2011 Sep; 53(1372):69-70. PubMed ID: 21897348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ticagrelor. Acute coronary syndromes: nothing new.
    Prescrire Int; 2011 Oct; 20(120):229-33. PubMed ID: 21970081
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The future of platelet function testing to guide therapy in clopidogrel low and enhanced responders.
    Bernlochner I; Byrne RA; Kastrati A; Sibbing D
    Expert Rev Cardiovasc Ther; 2011 Aug; 9(8):999-1014. PubMed ID: 21878045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ticagrelor in patients with acute coronary syndromes and stroke: interpretation of subgroups in clinical trials.
    James SK; Pieper KS; Cannon CP; Storey RF; Becker RC; Steg PG; Wallentin L; Harrington RA;
    Stroke; 2013 May; 44(5):1477-9. PubMed ID: 23572474
    [No Abstract]   [Full Text] [Related]  

  • 16. [Prasugrel for acute and long-term treatment of patients with acute coronary syndromes: what is state-of-the-art?].
    Silber S; Helms TM; Garlichs C; Arntz HR; Weil J; Ince H; Klingenheben T; Hoffmann S; Boudriot E; Steiger H; Zugck C
    Dtsch Med Wochenschr; 2011 Apr; 136(15):782-5. PubMed ID: 21432747
    [No Abstract]   [Full Text] [Related]  

  • 17. Ticagrelor for acute coronary syndromes.
    Bansilal S; Bonaca MP; Sabatine MS
    Expert Rev Cardiovasc Ther; 2013 Nov; 11(11):1473-84. PubMed ID: 24147518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ticagrelor FDA approval issues revisited.
    Serebruany VL
    Cardiology; 2012; 122(3):144-7. PubMed ID: 22832506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The ISAR-SAFE study].
    Capranzano P; Castiglioni B
    G Ital Cardiol (Rome); 2015 Jun; 16(6):331-5. PubMed ID: 26156693
    [No Abstract]   [Full Text] [Related]  

  • 20. Peripheral vascular outcomes in the PLATO trial: update from the FDA ticagrelor complete response review.
    Serebruany VL
    Am J Ther; 2012 Mar; 19(2):160-1. PubMed ID: 22395000
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 18.